Hypertension in Pregnancy:Timing of delivery and early screening by Zwertbroek, Eva
 
 





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Zwertbroek, E. (2020). Hypertension in Pregnancy: Timing of delivery and early screening.
https://doi.org/10.33612/diss.127418195
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020
Eva F. Zwertbroek, Julia Zwertbroek, Kim Broekhuijsen, Maureen T.M. Franssen, 
Wessel Ganzevoort, Josje Langenveld, Ben W. J. Mol, Marielle G. van Pampus, 
Sicco Scherjon, Anneloes L. van Baar, Henk Groen, for the HYPITAT-II Study Group
European Journal Obstetrics & Gynecology and Reproductive Biology. 2020 Jan;244:172-179
Neonatal developmental and behavioral outcomes
of immediate delivery versus expectant monitoring 
in mild hypertensive disorders of pregnancy: 
5-year outcomes of the HYPITAT II trial
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Objective: To compare effects of immediate delivery vs expectant monitoring 
on neurodevelopmental and behavioral outcomes at 5 years of age in offspring 
of women with mild late preterm hypertensive disorders .
Study design: We studied children born during the HYPITAT-II trial, in which 704 
women with a hypertensive disorder between 34 and 37 weeks of gestation 
were randomized to immediate delivery or expectant monitoring. Participating 
women were asked to complete the Ages and Stages Questionnaire (ASQ) for 
developmental outcome and the Child Behavior Checklist (CBCL) for behavioral 
problems when their child was 5 years old. Outcomes were dichotomized and 
analyzed by logistic regression analysis. We also assessed factors influencing 
development and behavior at both 2 and 5 years after a hypertensive pregnancy.
Results: Five years after the original study 322(46%) women were contacted for 
follow-up, of whom 148 (46%) responded. In the delivery group 22%(n=14/65) 
of the children had an abnormal ASQ score compared to 21% (n=13/62) in the 
expectant monitoring group (p=0.9). Abnormal CBCL-scores were found in 19% 
(n=14/72) of the children in the delivery group versus in 27% (n=20/75) in the 
expectant monitoring group (p=0.3). The main predictor of development and 
behavior at 2 and 5 years was fetal growth restriction (for abnormal development 
OR 2.1, CI 1.0 – 4.4; for behavior problems OR 2.2, CI 1.1-5.5). Higher maternal 
education decreased abnormal behavior outcomes (OR 0.5, CI 0.2 - 0.9) and a 
similar tendency was observed for developmental problems (OR 0.6, CI 0.3 – 1.1).
Conclusion: We did not find different developmental and behavior outcomes 
at 5 years of age between a management policy of immediate delivery and 
expectant management in preterm hypertensive disorders. The increased risk 
of developmental delay at 2 years of age after immediate delivery, we found in 
the 2 year follow up study, did not persist at 5 years of age.
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INTRODUCTION
Hypertensive disorders of pregnancy, which include gestational hypertension, 
preeclampsia, worsening chronic hypertension and superimposed preeclampsia, 
occur in 10% of all pregnancies.(1-3) These disorders carry both maternal and 
neonatal risk of mortality and morbidity.(4-6) Delivery of the baby remains the 
only way to definitively treat the disorder and prevent progression. At term 
this is the preferred management strategy, since it decreases maternal risk 
on progression of disease and adverse outcomes, without affecting neonatal 
outcomes.(7, 8) However, in preterm pregnancy there are neonatal risks to 
consider.
Preterm delivery is associated with neonatal mortality and morbidity such as 
respiratory distress syndrome (RDS), necrotizing enterocolitis and intraventricular 
hemorrhage.(9, 10) In addition, lower gestational age at delivery is known to 
be associated with long-term complications such as impaired neuromotor 
development and atypical psychosocial patterns. (11, 12)However, delayed delivery 
increases the risk of maternal complications of the hypertensive disease such 
as thromboembolic complications, pulmonary oedema, HELLP syndrome, 
eclampsia, placental abruption, or maternal death.(8, 13) Therefore, determining 
the most suitable course of action in case of a hypertensive disorder before term 
requires a balanced evaluation of maternal and neonatal risks, both in short and 
longer term.
This dilemma was addressed in the HYPITAT II study, which compared immediate 
delivery to expectant monitoring as management strategies in late preterm 
hypertensive disorders. We found that in the immediate delivery group 5.7% 
of the neonates were diagnosed with respiratory distress syndrome compared 
to 1.7% in the expectant monitoring group (RR 3.3; 95% CI, 1.4-8.2). However, 
adverse maternal outcomes did not differ significantly (1.1% in the immediate 
delivery group vs. 3.1% in the expectant monitoring group, RR 0.36; 95% CI, 0.12-
1.11).(14) Since immediate delivery did not decrease adverse maternal outcomes 
but significantly increased RDS, we concluded that expectant monitoring 
was preferred until delivery was clinically required in a preterm hypertensive 
pregnancy.
Since children born from a preeclamptic pregnancy are at increased risk 
of developmental problems, (15) we previously investigated the effect of 
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immediate versus deferred delivery in late preterm hypertensive disorders, on 
developmental and behavioral outcomes at the age of two. Behavioral outcomes 
were similar but infants in the immediate delivery group showed an increased 
rate of abnormal development (28% versus 18% in the expectant monitoring 
group (p=0.045)).(16)
To investigate whether this impaired neurodevelopment in the immediate 
delivery group at 2 years of age persists at a later age, we repeated this 
assessment at the age of 5. The aim of this study was to compare long term 
effects of immediate delivery vs. expectant monitoring on neurodevelopmental 




Our study population originates from the HYPITAT II trial, which ran from 2009 
until 2013 in the Netherlands.(14) The HYPITAT II randomized women with 
hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, 
worsening chronic hypertension or superimposed preeclampsia) between 34+0 
and 36+6 weeks of gestation to immediate delivery or expectant monitoring. 
In the first group labor was immediately induced whereas in the expectant 
monitoring group induction of labor only occurred if another indication arose 
or the gestational age of 37 weeks was reached. The Institutional review board 
of the Academic Medical Center in Amsterdam approved this study (08/244) 
and participants gave informed consent for this follow-up study at inclusion. 
Participants were included between 2014 and 2018.
Study procedures
In this follow-up study mothers of the HYPITAT II trial were approached when 
their infants reached 5 years of age. They were sent three questionnaires to be 
completed when their child was 5 years old; the Ages and Stages Questionnaire 
for developmental outcome, the Child Behavior Checklist for behavioral problems 
and a general background questionnaire. The questionnaires were included in 
the analysis if they were completed within the recommended age range, as 
specified per questionnaire.
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Ages and Stages Questionnaire
The Ages and Stages Questionnaire (ASQ) is a questionnaire developed to detect 
developmental delay by tracking age specific milestones.(17-19) ASQ adjusts 
for age and was previously validated for the age of 5.(20) The child should be 
between 57 and 66 months at time of ASQ completion. Parents were asked 
to score their child on five domains; communication, gross motor, fine motor, 
problem solving and personal-social. Each domain consists of 6 questions 
regarding skills for which parents could indicate if their child already showed 
it or not, and answer ‘not yet’, ‘sometimes’ or ‘yes’. Lower scores indicate less 
attainment of developmental milestones.(18) The questionnaire result was 
considered abnormal if the score was ≥2 SD below the expected mean of the 
Dutch reference population on one domain or ≥ 1 SD below reference on multiple 
domains.(17) Abnormal ASQ scores can indicate developmental delay.
Child Behavior Checklist
The Child Behavior Check list (CBCL) checks for behavioral problems in infants 
between 1.5 and 5 year old.(21, 22) It consists of 100 questions in which parents 
can indicate to what extent certain behavior problems are present currently, 
or in the last two months. The CBCL assesses seven narrow syndrome scales 
(emotionally reactive, anxious/depressed, somatic complaints, withdrawn, sleep 
problems, attention problems and aggressive behavior) and two broadband 
scales (internalizing and externalizing behavior). A standardized t-score was 
calculated for each scale. Borderline cut-off points are the 85th percentile 
(T-score ≥ 60) for the broadband scales and 95th percentile (T-score ≥ 65) for 
the narrowband scales.(22) Scores above these cut-off points were defined as 
abnormal, indicating increased risk of behavioral problems.(22)
Statistical analysis
Baseline characteristics and outcomes from the original HYPITAT II study 
were compared between respondents and non-respondents and between 
the randomization groups. Continuous variables were expressed as medians 
and interquartile range (IQR), dichotomous variables in absolute numbers and 
percentages. T-tests, Mann-Whitney U, Chi-square test or Fisher exact test were 
used to compare the groups as appropriate.
The primary outcomes, abnormal ASQ and CBCL scores, were compared 
between randomization groups using Chi-square test. As a secondary analysis an 
univariable logistic regression was performed to identify predictors of abnormal 
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development or behavioral problems at 5 years of age. Additionally, we merged 
the current 5-year follow-up cohort to the previously described 2-year follow-up 
cohort to assess factors of influence on development and behavior at both 2 and 
5 years after a hypertensive pregnancy. To address this question, a multi-level 
analysis using Generalized Estimating Equations with exchangeable correlation 
matrix structures was performed, which takes into account repeated measures 
within one individual.
RESULTS
Of the original 704 participants of the HYPITAT II study, 322 (45.7%) parents were 
approachable for this 5-year follow-up. Of the approached women 148 (45.9%) 
agreed to participate, of whom 72 (48.6%) were in the delivery group and 76 
(51.4%) in the expectant monitoring group. Including twins this resulted in a total 
of 153 completed questionnaires. Unfortunately, 6 (4.1%) CBCL and 26 (8.3%) ASQ 
questionnaires were discarded because they were either incomplete or filled in 
outside the correct age range (figure 1).
Baseline characteristics
The baseline characteristics of the respondents and non-respondents, as 
well as of the two management groups are shown in table 1. As an effect of 
randomization, the delivery group showed a significantly lower gestational age 
at delivery (36 vs. 37 weeks, p<0.001), and a significantly shorter time between 
inclusion and delivery (2 vs. 7 days, p<0.001) compared to the expectant 
monitoring group. We found no other significant differences in baseline and in 
neonatal outcomes between management groups (table 2).
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Figure 1. Flow chart of inclusions
ASQ, Ages and Stages Questionnaire; CBCL, Child Behavior Checklist; HYPITAT II, Hypertension 
and Pre-eclampsia Intervention Trial At near Term.
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Table 2. Neonatal outcomes




Difference in % 




Fetal growth restriction at study entry 5 (6.7%) 3 (3.8%) 2.9 (-4.2 to 10.0) 0.62





3070) -63 (-223 to 97) 0.44
Gestational age at birth (weeks) 36.1 (35.4-36.7) 37.0 (36.1-37.1) -0.61 (-0.88 to -0.34) <0.001
RDS 4 (5.3%) 1 (1.3%) 4.0 (-1.7 to 9.7) 0.16
5 min Apgar score <7 0 (0.0%) 3 (3.9%) -3.9 (-8.2 to 0.4) 0.08
Umbilical artery pH <7.05 * 2 (3.5%) 1 (1.5%) 2.0 (-3.0 to 7.0) 0.48
NICU admission 1 (1.3%) 0 (0.0%) 1.3 (1.3 to 3.9) 0.31
Sepsis (suspected infection) 7 (9.3%) 7 (9.0%) 0.3 (-8.8 to 9.4) 0.94
Hypoglycaemia 13 (17.3%) 5 (6.4%) 10.9 (0.8 to 21.0) 0.04
Transient tachypnoea of the newborn 3 (4.0%) 3 (3.8%) 0.2 (-5.9 to 6.3) 0.96
Meconium aspiration syndrome 0 (0.0%) 0 (0.0%) NA
Pneumothorax or pneumomediastinum 0 (0.0%) 0 (0.0%) NA
Periventricular leucomalacia 0 (0.0%) 0 (0.0%) NA
Intraventricular haemorrhage 0 (0.0%) 0 (0.0%) NA
Convulsions 0 (0.0%) 1 (1.3%) -1.3 (-3.8 to 1.2) 1.00
Necrotising enterocolitis 0 (0.0%) 0 (0.0%) NA
Any neonatal morbidity 28 (37.3%) 18 (23.1%) 14.2 (-0.2 to 28.6) 0.12
Age at completion of follow up (month) 61 (60-64) 61 (60-65) -0.5 (-1.77 to 0.72) 0.41
Data were compared between induction of labour and expectant management using Student t, 
Mann-Whitney U, Chi square or Fishers exact test. 
Table shows median (interquartile range) or number (%). 
n = number of neonates born in a certain cohort 
Data are given according to available data. 
* indicates a variable with >20% missing data
Developmental outcomes (ASQ)
In the immediate delivery group 21.5% (n=14) had an abnormal ASQ compared 
to 21.0% (n=13) of the expectant monitoring group (absolute difference 0.5%, 95% 
CI -13.7 to 14.7, p=0.94, figure 2). No statistically significant differences were found 
among the developmental domains between the management groups (table 3).
Binnenwerk Eva - V2.indd   56 27-05-20   09:47
57
Five year outcomes of the HYPITAT II
Behavioral problems (CBCL)
An abnormal CBCL score was found in 19.4% (n=14) of the immediate delivery 
group and 26.7% (n=20) of the expectant monitoring group (absolute difference 
7.3%, 95% CI -20.9 to 6.3, p=0.30, figure 2). On the CBCL subscale of somatic 
complaints 12% (n=9) of the children in the expectant monitoring group had 
an abnormal score as compared to 2.8% (n=2) in the immediate delivery group 
(absolute difference 9.2%, 95% CI -17.5 to -0.9, p=0.03, see table 3). No statistically 
significant differences were found in other behavioral problem scales.
Figure 2. Number of children with abnormal scores on Ages and Stages Questionnaire (ASQ) or 
Child Behaviour Checklist (CBCL)
Data were compared with Chi square test.
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percent (95% CI) p-value
Problem area ASQ ASQ n = 65 ASQ n = 62
Communication 5 (7.7%) 3 (4.8%) 2.9 (-5.5 to 11.3) 0.51
Gross motor 3 (4.6%) 2 (3.3%) 1.3 (-5.5 to 8.1) 0.72
Fine motor 5 (7.8%) 5 (8.1%) -0.3 (-9.7 to 9.1) 0.96
Problem solving 1 (1.6%) 4 (6.5%) -4.9 (-11.8 to 2.0) 0.17
Personal social 1 (1.6%) 3 (4.8%) -3.2 (-9.3 to 2.9) 0.29
total score 3 (4.9%) 3 (5.0%) -0.1 (-7.6 to 7.4) 0.98
Syndrome scale CBCL CBCL n = 72 CBCL n = 75
Emotionally reactive 6 (8.3%) 7 (9.3%) -1.0 (-10.2 to 8.2) 0.83
Anxious/depressed 4 (5.6%) 3 (4.0%) 1.6 (-5.3 to 8.5) 0.66
Somatic complaints 2 (2.8%) 9 (12.0%) -9.2 (-17.5 to -0.9) 0.03
Withdrawn 3 (4.2%) 3 (4.0%) 0.2 (-6.2 to 6.6) 0.96
Sleep problems 1 (1.4%) 1 (1.3%) 0.1 (-3.5 to 3.8) 0.98
Attention problems 6 (8.3%) 5 (6.7%) 1.6 (-6.9 to 10.1) 0.70
Agressive behavior 3 (4.2%) 3 (4.0%) 0.2 (6.2 to 6.6) 0.96
Internalizing 9 (12.5%) 6 (8.0%) 4.5 (-5.3 to 14.3) 0.37
Externalizing 6 (8.3%) 8 (10.7%) -2.4 (-11.9 to 7.1) 0.63
Total problem score 14 (19.4%) 20 (26.7%) -7.3 (-20.9 to 6.3) 0.30
Data were compared with Chi-square test. 
n = number of neonates with complete questionnaire
Predictors of abnormal ASQ or CBCL
Univariable analysis found no significant predictors of abnormal ASQ or CBCL 
score at 5 years of age in children born after a hypertensive pregnancy. Table 4 
shows the results of the multi-level analysis of possible predictors of abnormal 
ASQ and CBCL scores at both 2 and 5 years after the HYPITAT II study. Fetal 
growth restriction was associated with abnormal ASQ scores at 2 and 5 years of 
age (OR 2.1, 95% CI 1.0 to 4.4). Higher birthweight and higher maternal education 
did not decrease abnormal ASQ outcome rate although their effects bordered 
on significance (OR 0.7, 95% CI 0.4 to 1.1 and OR 0.6, 95% CI 0.3 to 1.1, respectively). 
In the analysis of all measurements at 2 and 5 years, abnormal development 
was not significantly associated with immediate delivery (OR 1.4, 95% CI 0.9 to 
2.3) or with the related variable younger gestational age at birth (OR 1.0, 95% CI 
0.8 to 1.3). Factors associated with abnormal CBCL scores at 2 and 5 years were 
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fetal growth restriction (OR 2.2, 95% CI 1.1 to 5.5) and maternal education (OR for 
higher education 0.5, 95% CI 0.2 to 0.9). In addition, abnormal outcomes at the 
age of 2 were significant predictors of abnormal outcomes at the age of five: for 
ASQ OR 5.5 (95%CI 1.7-17.9) and CBCL OR 4.8 (95%CI 1.6-14.9).
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COMMENT
Principal findings
In this follow-up study of the children 5 year after the HYPITAT II trial we found 
no difference in developmental and behavioral outcome between the two 
management groups (immediate delivery vs. expectant monitoring). We did 
find that fetal growth restriction was associated with poorer developmental 
and behavioral outcome at 2 and 5 years old. Additionally, maternal education 
predicted development at age 2 and behavioral outcome at 2 and 5 years old. In 
the 2-year follow-up data immediate delivery (and a slightly lower gestational age 
at delivery as a result of that) was associated with poorer development. At 5 years 
of age the effects of obstetric management on development did not persist.
Results in the context of what is known
Our cohort still showed a higher risk of abnormal development (21.3%) compared 
to the standard Dutch population, in which an abnormal score is expected for 
2.3%).(17) This strengthens previous studies that both hypertensive disorders 
and preterm birth are associated with increased risk of abnormal development.
(23-29) For behavioral outcomes the gap between the reference and the study 
population was less pronounced: by definition 17% of the reference population 
had a score above the borderline cut-off, compared to 16.1% in the 2-year follow-
up.(17) In this 5-year follow-up abnormal behavior scores varied from 19.4% in 
the delivery groups vs. 26.7% in the expectant monitoring group. This indicates 
a slightly elevated rate of behavior problems in our study compared to their 5 
year old peers.
This study did not confirm that gestational age at delivery is one of the main 
predictors of developmental and behavioral outcomes at the age of 5, as we 
found no significant relationship. A possible explanation might be that literature 
mainly focuses on preterm versus term delivery, while all participating infants in 
this trial were delivered preterm between 34 - 37 weeks.(15, 30) The small range 
of gestational ages might have contributed to the lack of a significant relation.
In literature both fetal growth restriction and birth weight are associated with 
poor neurodevelopment.(31, 32) Our 2-year follow-up study found birth weight 
as a predictor of development in consensus with literature. The current study 
showed a trend towards improved development with increasing birthweight and 
birthweight above the 10th centile. We found that fetal growth restriction was 
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significantly associated with abnormal development and behavior problems at 
both 2 and 5 years of age.
Besides the perinatal situation, maternal education, lifestyle factors and socio-
economic status are known to be associated with development, as we also 
reported for the outcomes at 2 year.(27) Additionally, the association between 
maternal education and behavioral outcomes at 2 and 5 years old emerged. A 
possible explanation for poorer developmental outcome at 2 years of age in the 
immediate delivery group, and the absence of this difference at 5 years could 
be that environmental factors such as maternal education and socio-economic 
status become more important for development at older ages.(33) Additionally, 
if a developmental delay is noticed early, early interventions at daycare or school 
can improve later development.(34, 35)
Strengths and limitations
Considering that obstetric interventions might influence outcomes in childhood, 
the HYPITAT II trial preplanned this long-term follow-up. The prediction 
of developmental outcomes in infancy is still challenging due to intensive 
neurodevelopmental processes occurring in this period.(36) Assessing the 
data from two time points makes it possible to monitor the progression of 
development in one child, having both short and long term follow-up.
This study was limited by a low follow-up rate due to logistic reasons. At 5 years 
after the original trial contact data were no longer up to date, making it difficult 
to approach all participants of the original study. As a result, our study may 
have insufficient power to detect subtle differences. Also, there is evidence of 
selective participation in this follow-up study: in the respondents group less 
adverse neonatal outcomes were observed, which may have influenced the 
results. Nevertheless, this is the only randomized controlled trial comparing 
two management strategies in preterm hypertensive disorders with a long 
term follow-up at two time points. Given the limitations of the study budget we 
performed a questionnaire study. Clinical examination rather than a questionnaire 
study would have been the most reliable tool to assess development and 
behavior, although parent completed screening questionnaires are proven to 
be reliable to detect developmental delay and behavior problems.(37, 38)
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Implication for clinical practice
The principal findings of the HYPITAT II and the 2-year follow-up study underline 
that in preterm hypertensive disorders expectant monitoring should be the 
management strategy of choice. The results of the 5-year follow-up indicate 
that the neonatal morbidity and impaired development at 2 years imposed by 
immediate delivery, diminish at later age. Apparently, long-term developmental 
and behavioral consequences of immediate delivery versus expectant 
management for the neonate are minimal in late preterm pregnancy. Expectant 
management poses the risk of progression of maternal disease and fetal growth 
restriction, which are both associated with poorer development. In the preferred 
general policy of expectant management in preterm hypertensive disorders, 
immediate delivery can be safely considered when maternal or fetal condition 
deteriorate without too much hesitation because of worries about the long-term 
effect on infant development.
Future perspectives
Longer and more detailed follow-up studies are needed to assess the effect of 
management in late preterm hypertensive disorders of pregnancy on behavior, 
cognitive and social-emotional development. In addition, other long term 
morbidity (cardiovascular, metabolic, respiratory, reproductive etcetera) that may 
result from prematurity should be addressed in follow up studies. We encourage 
researchers to integrate a long term follow up when designing an (obstetrical) 
clinical trial to evaluate these valuable parameters.
Conclusion
Neurodevelopmental and behavioral problems at the age of 5 are not associated 
with management strategy in late preterm hypertensive disorders. This study 
therefore underlines the conclusion of the original HYPITAT II study and its 2-year 
follow-up that expectant management is the preferred management strategy 
until progression of disease or term gestational age indicate otherwise.
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Supplementary figure 1. CONSORT 2010 Flow Diagram
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